Trying to learn how to translate from the human translation examples.
From professional translators, enterprises, web pages and freely available translation repositories.
proti diftérii (0,1 iu/ml)
anti-diphtheria (0.1 iu/ml)
Last Update: 2017-04-26
Usage Frequency: 5
Quality:
proti diftérii ( 0,01 iu/ml)
anti-diphtheria ( 0.01 iu/ml)
Last Update: 2017-04-26
Usage Frequency: 2
Quality:
klinický obraz zodpovedajúci respiračnej diftérii,
clinical picture compatible with either respiratory diphtheria,
Last Update: 2014-11-21
Usage Frequency: 2
Quality:
text o "diftÉrii" sa nahrádza takto:
the text on "diphtheria" is replaced by the following:
Last Update: 2014-11-21
Usage Frequency: 1
Quality:
Warning: Contains invisible HTML formatting
protilátky proti diftérii (0,1 iu/ml)
anti-diphtheria (0.1 iu/ml) †
Last Update: 2017-04-26
Usage Frequency: 3
Quality:
quintanrix je indikovaný na základnú imunizáciu detí (počas prvého roka života) proti diftérii, on
quintanrix is indicated for primary immunisation of infants (during the first year of life) against diphtheria, tetanus, pertussis, hepatitis b and invasive disease caused by haemophilus influenzae na
aj keď sa môže objaviť protilátková odpoveď na difterický toxoid, očkovanie touto vakcínou nenahrádza bežné očkovanie proti diftérii.
although some antibody response to diphtheria toxoid may occur, immunisation with this vaccine does not substitute for routine diphtheria immunisation.
precitlivenosť po predchádzajúcej aplikácii očkovacích látok proti diftérii, tetanu, pertussis, hepatitíde b alebo polio očkovacej látky.
hypersensitivity after previous administration of diphtheria, tetanus, pertussis, hepatitis b or polio vaccines.
precitlivenosť po predchádzajúcej aplikácii očkovacích látok proti diftérii, tetanu, pertussis, hepatitíde b, polio alebo hib očkovacej látky.
hypersensitivity after previous administration of diphtheria, tetanus, pertussis, hepatitis b, polio or hib vaccines.
ťo diftérii a proti tetanu ≥ 0, 1 iu/ ml celkovo 95, 5% a 99, 9% jedincov.
r ge studies show that, overall, 95.5% and 99.9% of subjects had anti-diphtheria and anti-tetanus titres ≥ 0.1 iu/ ml one month after completion of the primary vaccination course.
ochorenia postihujúceho horné dýchacie cesty s charakteristickými adherujúcimi pablanami na tonzilách, faryngu alebo v nose v kombinácii s bolesťami hrdla a mierne zvýšenou teplotou, alebo nerespiračnej diftérii,
an upper respiratory tract illness characterised by an adherent membrane of the tonsils, pharynx or nose, in combination with sore throat and low grade fever, or non-respiratory diphtheria;
protektívna imunita proti trom typom poliovírusu a prp sa pozorovala aspoň u 91,0 % detí a proti diftérii a tetanu aspoň u 64,7 % detí.
protective immunity against the three poliovirus types and prp was observed in at least 91.0% of children and against diphtheria and tetanus in at least 64.7% of children.
infanrix hexa je určený na základné očkovanie a aplikáciu booster dávky deťom proti diftérii, tetanu, pertussis, hepatitíde b, poliomyelitíde a pred ochorením, ktoré spôsobuje haemophilus influenzae typ b.
infanrix hexa is indicated for primary and booster vaccination of infants against diphtheria, tetanus, pertussis, hepatitis b, poliomyelitis and disease caused by haemophilus influenzae type b.
infanrix hexa – prášok a disperzné prostredie na injekčnú suspenziu očkovacia látka proti diftérii (d), tetanu (t), pertussis (acelulárna zložka) (pa), hepatitíde b (rdna) (hbv), poliomyelitíde (inaktivovaná) (ipv) a haemophilus typ b (konjugovaná, adsorbovaná) (hib)
infanrix hexa – powder and suspension for suspension for injection diphtheria (d), tetanus (t), pertussis (acellular component) (pa), hepatitis b (rdna) (hbv), poliomyelitis (inactivated) (ipv) and haemophilus type b (hib) conjugate vaccine (adsorbed)